
CASP8 / Caspase 8 Antibody (aa181-478, clone C15)
Primary AntibodyLSBio Guarantee
| Antibody: | Mouse Monoclonal |
| Applications: | Immunocytochemistry, Immunohistochemistry (general), Immunoprecipitation, Western Blot |
| Reactivity: | Human |
| Format: | Liquid |
$366.00each
Catalog Number: LS-C344789-50
Catalog Number: LS-C344789
For bulk orders or custom formulations:
Request a QuoteOverview
- Description
- Caspase 8 antibody LS-C344789 is an unconjugated mouse monoclonal antibody to human Caspase 8 (CASP8) (aa181-478). Validated for ICC, IP and WB. Cited in 1 publication.
- Application
- ICC, IHC, IP, WB
- Reactivity
- Hu
- Intended Use
- Research Use Only
- Guarantees
- This antibody carries the LSBio 100% Guarantee. ✓
- Category
- Antibodies > Primary Antibodies > Monoclonal Antibodies
- Alternative Names
- ALPS2B | Apoptotic protease Mch-5 | Apoptotic cysteine protease | Casp-8 | Caspase-8 | CAP4 | Caspase 8 | MACH | MCH5 | MORT1-associated ced-3 homolog | ICE-like apoptotic protease 5 | Pro Caspase 8 | CASP8 | FADD-like ICE | FLICE | MACH-alpha-1/2/3 protein | MACH-beta-1/2/3/4 protein
- UniProt Number
- Q14790
- NCBI GenBank
- AAC50645.1 | nm_001228
- SwissProt
- Q14790
Target
- Target
- Human CASP8 / Caspase 8
- Antigen Species
- Human
- Epitope
- Recognizes the p18 subunit of human caspase-8.
- Gene Name
- CASP8
Antibody
- Host Species
- Mouse
- Clonality
- Monoclonal
- Clone
- C15
- Isotype
- IgG2b
Immunogen
- Immunogen
- Recombinant human caspase-8 (aa 181-478).
- Immunogen Type
- Recombinant Protein Fragment
Format
- Conjugate/Label
- Unconjugated
- Format
- Liquid
- Formulation
- PBS, 0.02% Sodium Azide, 10% Glycerol
- Preservative
- Yes
- Purification Method
- Protein G Affinity
Storage & Handling
- Storage Conditions
- Short term: store at 4°C. Long term: store at -20°C. Avoid freeze-thaw cycles.
- Recommended Storage Buffer
- PBS
ARHGEF4 predicts poor prognosis and promotes cell invasion by influencing ERK1/2 and GSK-3a/ß signaling in pancreatic cancer. Keisuke Taniuchi, Mutsuo Furihata, Seiji Naganuma, Toshiji Saibara. International journal of oncology. 2018 Nov;53:2224-2240. PubMed: 30226582
